Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018

BackgroundUnderstanding the association between relative mortality with body mass index (BMI) may aid clinicians in making suitable clinical decisions. Our study evaluated the impact of BMI on mortality among cancer survivors.MethodsWe used data from the US National Health and Nutrition Examination...

Full description

Bibliographic Details
Main Authors: Yi Yang, Dan Chen, Dingfu Zhong, Zongbi Yi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1180442/full
_version_ 1797828952489721856
author Yi Yang
Dan Chen
Dingfu Zhong
Zongbi Yi
author_facet Yi Yang
Dan Chen
Dingfu Zhong
Zongbi Yi
author_sort Yi Yang
collection DOAJ
description BackgroundUnderstanding the association between relative mortality with body mass index (BMI) may aid clinicians in making suitable clinical decisions. Our study evaluated the impact of BMI on mortality among cancer survivors.MethodsWe used data from the US National Health and Nutrition Examination Surveys (NHANES) spanning from 1999 to 2018. Relevant mortality data were retrieved up until December 31, 2019. Adjusted Cox models were employed to examine the association of BMI with the risks for total and cause-specific mortality.ResultsAmong 4135 cancer survivors, 1486 (35.9%) were obese (21.0% class 1 obesity [BMI 30-< 35 kg/m2], 9.2% class 2 obesity [BMI 35 -< 40 kg/m2], 5.7% class 3 obesity [BMI ≥ 40 kg/m2]), 1475(35.7%) were overweight (BMI 25-< 30 kg/m2). During an average follow-up of 8.9 years (35895 person-years), a total of 1361 deaths were reported (cancer 392; 356 cardiovascular disease [CVD]; 613, non-cancer, non-CVD). In multivariable models, underweight participants (BMI < 18.5 kg/m2) were associated with significantly higher risks of cancer-specific (HR, 3.31; 95% CI, 1.37-8.03, P=0.01) and CVD cause (HR, 3.18; 95% CI, 1.44-7.02, P < 0.001) mortality compared to individuals with normal weight. Being overweight was associated with significantly lower risks of non-cancer, non-CVD cause mortality (HR, 0.66; 95% CI, 0.51-0.87, P < 0.001). Class 1 obesity was associated with significantly reduced risks of all-cause (HR, 0.78; 95% CI, 0.61-0.99, P = 0.04), and non-cancer, non-CVD cause (HR, 0.60; 95% CI, 0.42-0.86, P = 0.01) mortality. A higher risk of CVD-related mortality (HR, 2.35; 95% CI, 1.07-5.18, P = 0.03) was observed in class 3 obesity cases. Lower risks of all-cause mortality were detected in men (overweight, HR, 0.76; 95% CI, 0.59-0.99, P=0.04; class 1 obesity, HR, 0.69; 95% CI, 0.49-0.98, P = 0.04) but not in woman, in never-smokers (class 1 obesity, HR, 0.61; 95% CI, 0.41-0.90, P=0.01) and former smokers (overweight, HR, 0.77; 95% CI, 0.60-0.98, P=0.04) but not in current smokers; in obesity-related cancer (class 2 obesity, HR, 0.49; 95% CI, 0.27-0.89, P=0.01) but not in non-obesity-related cancers.ConclusionsIn the United States, cancer survivors with overweight or moderate obesity (class 1 or class 2 obesity) demonstrated a lower risk of all-cause and noncancer, non-CVD cause mortality.
first_indexed 2024-04-09T13:12:39Z
format Article
id doaj.art-a7a1e3b7b2ef444d94f2d27dc75ecebe
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T13:12:39Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a7a1e3b7b2ef444d94f2d27dc75ecebe2023-05-12T06:31:29ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.11804421180442Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018Yi Yang0Dan Chen1Dingfu Zhong2Zongbi Yi3Department of Gastroenterology, Jinhua People’s Hospital, Jinhua, Zhejiang, ChinaDepartment of Gastroenterology, Jinhua People’s Hospital, Jinhua, Zhejiang, ChinaDepartment of Gastroenterology, Jinhua People’s Hospital, Jinhua, Zhejiang, ChinaHubei Key Laboratory of Tumor Biological Behaviors, Department of Radiation and Medical Oncology, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, ChinaBackgroundUnderstanding the association between relative mortality with body mass index (BMI) may aid clinicians in making suitable clinical decisions. Our study evaluated the impact of BMI on mortality among cancer survivors.MethodsWe used data from the US National Health and Nutrition Examination Surveys (NHANES) spanning from 1999 to 2018. Relevant mortality data were retrieved up until December 31, 2019. Adjusted Cox models were employed to examine the association of BMI with the risks for total and cause-specific mortality.ResultsAmong 4135 cancer survivors, 1486 (35.9%) were obese (21.0% class 1 obesity [BMI 30-< 35 kg/m2], 9.2% class 2 obesity [BMI 35 -< 40 kg/m2], 5.7% class 3 obesity [BMI ≥ 40 kg/m2]), 1475(35.7%) were overweight (BMI 25-< 30 kg/m2). During an average follow-up of 8.9 years (35895 person-years), a total of 1361 deaths were reported (cancer 392; 356 cardiovascular disease [CVD]; 613, non-cancer, non-CVD). In multivariable models, underweight participants (BMI < 18.5 kg/m2) were associated with significantly higher risks of cancer-specific (HR, 3.31; 95% CI, 1.37-8.03, P=0.01) and CVD cause (HR, 3.18; 95% CI, 1.44-7.02, P < 0.001) mortality compared to individuals with normal weight. Being overweight was associated with significantly lower risks of non-cancer, non-CVD cause mortality (HR, 0.66; 95% CI, 0.51-0.87, P < 0.001). Class 1 obesity was associated with significantly reduced risks of all-cause (HR, 0.78; 95% CI, 0.61-0.99, P = 0.04), and non-cancer, non-CVD cause (HR, 0.60; 95% CI, 0.42-0.86, P = 0.01) mortality. A higher risk of CVD-related mortality (HR, 2.35; 95% CI, 1.07-5.18, P = 0.03) was observed in class 3 obesity cases. Lower risks of all-cause mortality were detected in men (overweight, HR, 0.76; 95% CI, 0.59-0.99, P=0.04; class 1 obesity, HR, 0.69; 95% CI, 0.49-0.98, P = 0.04) but not in woman, in never-smokers (class 1 obesity, HR, 0.61; 95% CI, 0.41-0.90, P=0.01) and former smokers (overweight, HR, 0.77; 95% CI, 0.60-0.98, P=0.04) but not in current smokers; in obesity-related cancer (class 2 obesity, HR, 0.49; 95% CI, 0.27-0.89, P=0.01) but not in non-obesity-related cancers.ConclusionsIn the United States, cancer survivors with overweight or moderate obesity (class 1 or class 2 obesity) demonstrated a lower risk of all-cause and noncancer, non-CVD cause mortality.https://www.frontiersin.org/articles/10.3389/fonc.2023.1180442/fullbody mass index (BMI)all-cause mortalityobesitycancer survivorsNational Health and Nutrition Examination Survey (NHANES)
spellingShingle Yi Yang
Dan Chen
Dingfu Zhong
Zongbi Yi
Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
Frontiers in Oncology
body mass index (BMI)
all-cause mortality
obesity
cancer survivors
National Health and Nutrition Examination Survey (NHANES)
title Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
title_full Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
title_fullStr Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
title_full_unstemmed Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
title_short Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018
title_sort association of body mass index with survival in u s cancer survivors a cross sectional study of nhanes 1999 2018
topic body mass index (BMI)
all-cause mortality
obesity
cancer survivors
National Health and Nutrition Examination Survey (NHANES)
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1180442/full
work_keys_str_mv AT yiyang associationofbodymassindexwithsurvivalinuscancersurvivorsacrosssectionalstudyofnhanes19992018
AT danchen associationofbodymassindexwithsurvivalinuscancersurvivorsacrosssectionalstudyofnhanes19992018
AT dingfuzhong associationofbodymassindexwithsurvivalinuscancersurvivorsacrosssectionalstudyofnhanes19992018
AT zongbiyi associationofbodymassindexwithsurvivalinuscancersurvivorsacrosssectionalstudyofnhanes19992018